Drug recall · June 24, 2015
NEXIUM¿ recall
Why: Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.
- Lots / codes
Lot # FC0064; Exp. 05/17
- Quantity
- 34,524 bottles
- Company
- AstraZeneca Pharmaceuticals LP, Wilmington, DE
- Distribution
- Nationwide to wholesalers for further distribution at the retail level.
- Initiated
- June 10, 2015 · Voluntary: Firm initiated
- Classified
- June 18, 2015
- Reported
- June 24, 2015
- Ended
- September 27, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nexium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.